Nevertheless, a systematic review reported that only three out of seven studies verified a positive correlation between serum RBP4 levels and liver histology among patients with biopsy-proven NAFLD [81]. This evidence concerns the gene RBP4 and metabolic dysfunction-associated steatotic liver disease.